Class information for:
Level 2: ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//SUMO

Basic class information

ID Publications Average number
of references
Avg. shr. active
ref. in WoS
1728 6064 42.8 88%



Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)



ID, lev.
above
Publications Label for level above
443 24079 ACUTE PROMYELOCYTIC LEUKEMIA//ARSENIC TRIOXIDE//VITAMIN A

Classes in level below (level 1)



ID, lev. below Publications Label for level below
2398 2189 ACUTE PROMYELOCYTIC LEUKEMIA//PML RAR ALPHA//APL
4429 1714 SUMO//SUMOYLATION//UBC9
10298 1009 ARSENIC TRIOXIDE//AS2O3//ARSENIC TRIOXIDE AS2O3
15757 624 DAXX//PML//PML NUCLEAR BODIES
22099 337 HIPK2//CACYBP SIP//CACYBP
27292 191 REALGAR//ALACRANITE//PARAREALGAR

Terms with highest relevance score



Rank Term Type of term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 ACUTE PROMYELOCYTIC LEUKEMIA Author keyword 649 66% 10% 607
2 ARSENIC TRIOXIDE Author keyword 568 63% 9% 570
3 SUMO Author keyword 239 54% 5% 306
4 SUMOYLATION Author keyword 154 48% 4% 239
5 PML RAR ALPHA Author keyword 138 76% 2% 96
6 APL Author keyword 117 52% 3% 160
7 UBC9 Author keyword 103 65% 2% 98
8 ALL TRANS RETINOIC ACID Author keyword 88 26% 5% 298
9 ACUTE PROMYELOCYTIC LEUKAEMIA Author keyword 82 60% 1% 89
10 HIPK2 Author keyword 72 69% 1% 61

Web of Science journal categories

Author Key Words



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
LCSH search Wikipedia search
1 ACUTE PROMYELOCYTIC LEUKEMIA 649 66% 10% 607 Search ACUTE+PROMYELOCYTIC+LEUKEMIA Search ACUTE+PROMYELOCYTIC+LEUKEMIA
2 ARSENIC TRIOXIDE 568 63% 9% 570 Search ARSENIC+TRIOXIDE Search ARSENIC+TRIOXIDE
3 SUMO 239 54% 5% 306 Search SUMO Search SUMO
4 SUMOYLATION 154 48% 4% 239 Search SUMOYLATION Search SUMOYLATION
5 PML RAR ALPHA 138 76% 2% 96 Search PML+RAR+ALPHA Search PML+RAR+ALPHA
6 APL 117 52% 3% 160 Search APL Search APL
7 UBC9 103 65% 2% 98 Search UBC9 Search UBC9
8 ALL TRANS RETINOIC ACID 88 26% 5% 298 Search ALL+TRANS+RETINOIC+ACID Search ALL+TRANS+RETINOIC+ACID
9 ACUTE PROMYELOCYTIC LEUKAEMIA 82 60% 1% 89 Search ACUTE+PROMYELOCYTIC+LEUKAEMIA Search ACUTE+PROMYELOCYTIC+LEUKAEMIA
10 HIPK2 72 69% 1% 61 Search HIPK2 Search HIPK2

Key Words Plus



Rank Web of Science journal category Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of publ.
in class
1 SUMOYLATION 335 61% 6% 358
2 PML RAR ALPHA 327 62% 6% 340
3 T15 17 TRANSLOCATION 327 78% 4% 215
4 ACUTE PROMYELOCYTIC LEUKEMIA 319 22% 21% 1283
5 RAR ALPHA 311 49% 8% 467
6 TRANS RETINOIC ACID 211 24% 13% 766
7 PROTEIN SUMOYLATION 194 82% 2% 112
8 DIFFERENTIATION THERAPY 184 54% 4% 234
9 AS2O3 168 74% 2% 126
10 PML 165 36% 6% 372

Journals

Reviews



Title Publ. year Cit. Active references % act. ref.
to same field
Concepts in sumoylation: a decade on 2007 701 135 88%
Sumoylation: A Regulatory Protein Modification in Health and Disease 2013 99 216 83%
Acute promyelocytic leukemia: from highly fatal to highly curable 2008 394 81 94%
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition 2010 279 132 88%
SUMO: A history of modification 2005 821 109 83%
Protein modification by SUMO 2004 888 194 82%
Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies 2007 399 117 79%
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet 2009 254 115 79%
Mechanisms, regulation and consequences of protein SUMOylation 2010 172 160 81%
Function and regulation of SUMO proteases 2012 77 119 83%

Address terms



Rank Address term Relevance score
(tfidf)
Class's shr.
of term's tot.
occurrences
Shr. of publ.
in class containing
term
Num. of
publ. in
class
1 UMR 7212 23 86% 0.2% 12
2 SHANGHAI HEMATOL 20 25% 1.2% 71
3 NEW FRONTIER SCI 13 62% 0.2% 13
4 GLOBAL INITIAT PULSED POWER ENGN 11 78% 0.1% 7
5 CELLULAR SENESCENCE GRP 8 60% 0.1% 9
6 HUMAN GENETSLOAN KETTERING 8 100% 0.1% 5
7 MOL ONCOGENESIS 7 19% 0.5% 32
8 HARRY B AILEEN B GORDON DIABET 6 80% 0.1% 4
9 UMR 944 6 71% 0.1% 5
10 CNRSUPR 9051 6 100% 0.1% 4

Related classes at same level (level 2)



Rank Relatedness score Related classes
1 0.0000013954 BRANCHIO OCULO FACIAL SYNDROME//RIZ1//BCL6
2 0.0000013097 METHYLSULFONYLMETHANE//LEUKEMIA CELL DIFFERENTIATION//N ACETYL S N METHYLCARBAMOYLCYSTEINE
3 0.0000012558 VITAMIN A//RETINOIC ACID//RETINOIDS
4 0.0000011912 MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA
5 0.0000011452 PROTEASOME//UBIQUITIN//NEDD8
6 0.0000009044 ARSENIC//ARSENIC SPECIATION//ARSENITE
7 0.0000006850 P73//MDM2//P53
8 0.0000006280 GRANULOCYTIC SARCOMA//CHLOROMA//TUMOR LYSIS SYNDROME
9 0.0000005959 PROTEIN KINASE D//PROTEIN KINASE D PKD//MEF2C
10 0.0000005941 NUCLEAR ENVELOPE//NUCLEAR PORE COMPLEX//NUCLEAR LAMINA